Becton Dickinson And Co logo

BDXA - Becton Dickinson And Co Share Price

$66.14 0.2  0.2%

Last Trade - 21/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £57.65bn
Enterprise Value £72.08bn
Revenue £13.25bn
Position in Universe 139th / 6416
Bullish
Bearish
Unlock BDXA Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BDXA Revenue Unlock BDXA Revenue

Net Income

BDXA Net Income Unlock BDXA Revenue

Normalised EPS

BDXA Normalised EPS Unlock BDXA Revenue

PE Ratio Range

BDXA PE Ratio Range Unlock BDXA Revenue

Dividend Yield Range

BDXA Dividend Yield Range Unlock BDXA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BDXA EPS Forecasts Unlock BDXA Revenue
Profile Summary

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Directors
Last Annual September 30th, 2019
Last Interim September 30th, 2019
Incorporated November 13, 1906
Public Since September 25, 1963
No. of Shareholders: 13,277
No. of Employees: 70,093
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange New York Stock Exchange (Dual Listing)
Shares in Issue 5,420,234,960
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BDXA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to BDXA
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.